# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001641489-26-000019
Filing Date
2026-05-13
Accepted
2026-05-13 16:18:25
Documents
13
Period of Report
2026-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | vtvt-20260513.htm iXBRL | 8-K | 25314
2 | EX-99.1 | vtvt-20260331xexx991pressr.htm | EX-99.1 | 82050
6 | GRAPHIC | newvtvimage30042424a.jpg | GRAPHIC | 684980
| Complete submission text file | 0001641489-26-000019.txt |  | 1164875

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | vtvt-20260513.xsd | EX-101.SCH | 1794
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | vtvt-20260513_lab.xml | EX-101.LAB | 21629
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | vtvt-20260513_pre.xml | EX-101.PRE | 12516
17 | EXTRACTED XBRL INSTANCE DOCUMENT | vtvt-20260513_htm.xml | XML | 2829

Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

EIN.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 26973582
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)